- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
55
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
55 companies
Laboratorios Farmaceuticos Rovi
Market Cap: €2.9b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€57.15
7D
-6.5%
1Y
-23.0%
Saudi Pharmaceutical Industries and Medical Appliances
Market Cap: ر.س3.5b
Develops, manufactures, and markets of medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middles East, Egypt, and Morocco.
2070
ر.س29.04
7D
-4.2%
1Y
-11.2%
LigaChem Biosciences
Market Cap: ₩5.5t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩150,600.00
7D
-1.1%
1Y
22.0%
Nanjing Vazyme Biotech
Market Cap: CN¥9.1b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥22.77
7D
-1.9%
1Y
0.8%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.4b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳300.00
7D
-2.4%
1Y
-9.0%
PolyPeptide Group
Market Cap: CHF 798.4m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 24.20
7D
-3.2%
1Y
-10.4%
Innovent Biologics
Market Cap: HK$160.9b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$93.95
7D
-4.1%
1Y
92.3%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.6b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€51.50
7D
-4.0%
1Y
-2.0%
MGI Tech
Market Cap: CN¥28.4b
Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.
688114
CN¥68.91
7D
-0.4%
1Y
35.1%
Beijing Aosaikang Pharmaceutical
Market Cap: CN¥18.5b
Beijing Aosaikang Pharmaceutical Co., Ltd.
002755
CN¥19.98
7D
-3.6%
1Y
58.3%
Chugai Pharmaceutical
Market Cap: JP¥12.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,479.00
7D
7.2%
1Y
5.3%
ST PharmLtd
Market Cap: ₩1.9t
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
A237690
₩90,300.00
7D
1.7%
1Y
-17.0%
Yuhan
Market Cap: ₩9.0t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩120,700.00
7D
0.7%
1Y
-25.2%
CanSino Biologics
Market Cap: HK$15.8b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$47.00
7D
-9.8%
1Y
80.8%
AcrobiosystemsLtd
Market Cap: CN¥10.3b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥61.40
7D
3.1%
1Y
128.3%
Sartorius Stedim Biotech
Market Cap: €18.3b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€187.60
7D
-5.5%
1Y
-0.3%
Celltrion
Market Cap: ₩38.2t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩173,600.00
7D
-1.0%
1Y
-3.9%
RemeGen
Market Cap: HK$54.5b
A biopharmaceutical company, discovers, develops, produces and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$93.35
7D
-25.3%
1Y
486.4%
Repligen
Market Cap: US$8.2b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$145.24
7D
-2.3%
1Y
4.6%